Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2–, PIK3CA-mutated breast cancers

Overview of attention for article published in Genome Medicine, April 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 3 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 228 followers.

Happy to have contributed to this study showing that patients with clonal multi-PIK3CA alterations have better responses to taselisib than patients with subclonal multi-PIK3CA. Clonal context matters. https://t.co/fupr2z0Cp0 https://t.co/jnf44jfCSs

26 Apr 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.